|
Coagulation inhibitors
Citations 11-20 of 44 total displayed.
|
Past content
(since Apr 2001):
|
- Articles
A Replacement for Warfarin. The Search Continues
- John W. Eikelboom and Jeffrey I. Weitz
Circulation published June 18, 2007, doi:10.1161/CIRCULATIONAHA.107.712349
[Abstract]
- Articles
Treatment of Proximal Deep-Vein Thrombosis With the Oral Direct Factor Xa Inhibitor Rivaroxaban (BAY 59-7939). The ODIXa-DVT (Oral Direct Factor Xa Inhibitor BAY 59-7939 in Patients With Acute Symptomatic Deep-Vein Thrombosis) Study
- Giancarlo Agnelli, Alexander Gallus, Samuel Z. Goldhaber, Sylvia Haas, Menno V. Huisman, Russel D. Hull, Ajay K. Kakkar, Frank Misselwitz, Sebastian Schellong for the ODIXa-DVT Study Investigators
Circulation published June 18, 2007, doi:10.1161/CIRCULATIONAHA.106.668020
[Abstract]
- Stroke
Targeting Platelets in Acute Experimental Stroke: Impact of Glycoprotein Ib, VI, and IIb/IIIa Blockade on Infarct Size, Functional Outcome, and Intracranial Bleeding
- Christoph Kleinschnitz, Miroslava Pozgajova, Mirko Pham, Martin Bendszus, Bernhard Nieswandt, and Guido Stoll
Circulation 2007;115:2323-2330; published online before print as doi:10.1161/CIRCULATIONAHA.107.691279
[Abstract]
[Full text]
- Articles
Targeting Platelets in Acute Experimental Stroke. Impact of Glycoprotein Ib, VI, and IIb/IIIa Blockade on Infarct Size, Functional Outcome, and Intracranial Bleeding
- Christoph Kleinschnitz, Miroslava Pozgajova, Mirko Pham, Martin Bendszus, Bernhard Nieswandt, and Guido Stoll
Circulation published April 16, 2007, doi:10.1161/CIRCULATIONAHA.107.691279
[Abstract]
- Vascular Medicine
First-in-Human Experience of an Antidote-Controlled Anticoagulant Using RNA Aptamer Technology: A Phase 1a Pharmacodynamic Evaluation of a Drug-Antidote Pair for the Controlled Regulation of Factor IXa Activity
- Christopher K. Dyke, Steven R. Steinhubl, Neal S. Kleiman, Richard O. Cannon, Laura G. Aberle, Min Lin, Shelley K. Myles, Chiara Melloni, Robert A. Harrington, John H. Alexander, Richard C. Becker, and Christopher P. Rusconi
Circulation 2006;114:2490-2497; published online before print as doi:10.1161/CIRCULATIONAHA.106.668434
[Abstract]
[Full text]
- Preventive Cardiology
A Once-Daily, Oral, Direct Factor Xa Inhibitor, Rivaroxaban (BAY 59-7939), for Thromboprophylaxis After Total Hip Replacement
- Bengt I. Eriksson, Lars C. Borris, Ola E. Dahl, Sylvia Haas, Menno V. Huisman, Ajay K. Kakkar, Eva Muehlhofer, Christoph Dierig, Frank Misselwitz, Peter Kälebo for the ODIXa-HIP Study Investigators
Circulation 2006;114:2374-2381; published online before print as doi:10.1161/CIRCULATIONAHA.106.642074
[Abstract]
[Full text]
- Articles
A Once-Daily, Oral, Direct Factor Xa Inhibitor, Rivaroxaban (BAY 59-7939), for Thromboprophylaxis After Total Hip Replacement
- Bengt I. Eriksson, Lars C. Borris, Ola E. Dahl, Sylvia Haas, Menno V. Huisman, Ajay K. Kakkar, Eva Muehlhofer, Christoph Dierig, Frank Misselwitz, Peter Kälebo for the ODIXa-HIP Study Investigators
Circulation published November 20, 2006, doi:10.1161/CIRCULATIONAHA.106.642074
[Abstract]
- Correspondence
Letter by Poston Regarding Article, "Effect of Clopidogrel Premedication in Off-Pump Cardiac Surgery: Are We Forfeiting the Benefits of Reduced Hemorrhagic Sequelae?"
- Robert Poston
Circulation 2006;114:e589, doi:10.1161/CIRCULATIONAHA.106.638544
[Full text]
- Articles
First-in-Human Experience of an Antidote-Controlled Anticoagulant Using RNA Aptamer Technology. A Phase 1a Pharmacodynamic Evaluation of a Drug-Antidote Pair for the Controlled Regulation of Factor IXa Activity
- Christopher K. Dyke, Steven R. Steinhubl, Neal S. Kleiman, Richard O. Cannon, Laura G. Aberle, Min Lin, Shelley K. Myles, Chiara Melloni, Robert A. Harrington, John H. Alexander, Richard C. Becker, and Christopher P. Rusconi
Circulation published November 13, 2006, doi:10.1161/CIRCULATIONAHA.106.668434
[Abstract]
- Cardiovascular Surgery
Effect of Clopidogrel Premedication in Off-Pump Cardiac Surgery: Are We Forfeiting the Benefits of Reduced Hemorrhagic Sequelae?
- Emmanouil I. Kapetanakis, Diego A. Medlam, Kathleen R. Petro, Elizabeth Haile, Peter C. Hill, Mercedes K.C. Dullum, Ammar S. Bafi, Steven W. Boyce, and Paul J. Corso
Circulation 2006;113:1667-1674; published online before print as doi:10.1161/CIRCULATIONAHA.105.571828
[Abstract]
[Full text]
|
|
